FTO and head and neck squamous cell carcinoma: Together, our findings demonstrate that genetic and pharmacologic inhibition of FTO enhances the radiation response in preclinical models of HPV– HNSCC, indicating the therapeutic potential of FTO inhibitors as a strategy to radiosensitize HNSCC.